University of Munich and CCC of LMU[Aff... Publications

Clinical Trial Review Systematic Review Meta-Analysis Books and Documents Randomized Controlled Trial

1 results match your criteria: "University of Munich and CCC of LMU[Affiliation]"

Page 1 of 1

Comparison of prognostic and predictive impact of genomic or central grade and immunohistochemical subtypes or IHC4 in HR+/HER2- early breast cancer: WSG-AGO EC-Doc Trial.

Ann Oncol

June 2016

West German Study Group, Moenchengladbach; Breast Center, University of Munich and CCC of LMU, Munich, Germany.

O Gluz C Liedtke J Huober H Peyro-Saint-Paul R E Kates

Introduction: Potential prognostic and predictive markers in early, intermediate-risk breast cancer (BC) include histological grade, Ki-67, genomic signatures, e.g. genomic grade index (GGI), and intrinsic subtypes.

View Article and Find Full Text PDF

Similar Publications

Geographic Location

Publish Date

Article Type

Comparison of prognostic and predictive impact of genomic or central grade and immunohistochemical subtypes or IHC4 in HR+/HER2- early breast cancer: WSG-AGO EC-Doc Trial.